QUESTION: What is the role of daratumumab in the treatment of Amyloidosis?
ANSWER: The use of daratumumab in patients with clinical symptoms of amyloidosis currently should not be recommended due to the weakness of the evidence available to support it. 11. Anzai, Adriano et. al. Use of daratumumab in patients with amyloidosis. Rev Assoc Med Bras 2020; 66(11):1468-1471.
REFERENCES
-
1Anzai, Adriano et. al. Use of daratumumab in patients with amyloidosis. Rev Assoc Med Bras 2020; 66(11):1468-1471.
Publication Dates
-
Publication in this collection
16 Dec 2020 -
Date of issue
Dec 2020